We are live on ! Find out more
AVDL

Avadel Pharmaceuticals
AVDL

Delisted

AVDL was delisted on the 11th of February, 2026.

Back to rankings

45 hedge funds and large institutions have $55.9M invested in Avadel Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

98% more capital invested

Capital invested by funds: $28.2M → $55.9M (+$27.7M)

30% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 10

0.7% less ownership

Funds ownership: 52.49% → 51.79% (-0.7%)

8% less funds holding

Funds holding: 49 → 45 (-4)

40% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 10

75% less call options, than puts

Call options by funds: $23K | Put options by funds: $92K

Holders
45
Holders Change
-4
Holders Change %
-8.16%
% of All Funds
0.98%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
6
Increased
13
Reduced
10
Closed
10
Calls
$23K
Puts
$92K
Net Calls
-$69K
Net Calls Change
-$69K

Top Buyers

Rank Fund Capital Flow
1
Ameriprise
Ameriprise
Minnesota
+$347K
2
CIBC Private Wealth Group
CIBC Private Wealth Group
Georgia
+$258K
3
Renaissance Technologies
Renaissance Technologies
New York
+$248K
4
BCM
Brown Capital Management
Maryland
+$214K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$123K

Top Sellers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$1.08M
2
BIP
Brandes Investment Partners
California
-$461K
3
Millennium Management
Millennium Management
New York
-$93K
4
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
-$52.7K
5
WS
Wedbush Securities
California
-$51K
Name Holding Trade Value Shares
Change 		Change in
Stake
CLOS
26
Compagnie Lombard Odier SCmA
Switzerland
$55K – – –
D.E. Shaw & Co
27
D.E. Shaw & Co
New York
$50K -$28.3K -16,470 -49%
Northern Trust
28
Northern Trust
Illinois
$45K -$2.02K -1,178 -7%
Envestnet Asset Management
29
Envestnet Asset Management
Illinois
$44K +$7.32K +4,259 +39%
CAM
30
Close Asset Management
United Kingdom
$43K – – –
State of New Jersey Common Pension Fund D
31
State of New Jersey Common Pension Fund D
New Jersey
$36K -$2.68K -1,561 -11%
Northwestern Mutual Wealth Management
32
Northwestern Mutual Wealth Management
Wisconsin
$29K – – –
Group One Trading
33
Group One Trading
Illinois
$18K +$8.01K +4,662 +283%
TRCT
34
Tower Research Capital (TRC)
New York
$8K +$4.22K +2,456 +1,554%
UBS Group
35
UBS Group
Switzerland
$6K +$3.27K +1,902 +1,829%
Citigroup
36
Citigroup
New York
$5K -$2.95K -1,718 -50%
IWA
37
IBEX Wealth Advisors
New Jersey
$4K +$2.58K +1,500 New
Wells Fargo
38
Wells Fargo
California
$3K – – –
BWP
39
Baldwin Wealth Partners
Massachusetts
$2K – – –
AG
40
Advisor Group
Arizona
$2K +$57 +33 +4%
WC
41
Whitnell & Co
Illinois
$1K – – –
Millennium Management
42
Millennium Management
New York
– -$93K -64,728 Closed
WS
43
Wedbush Securities
California
– -$51K -35,535 Closed
State of Tennessee, Department of Treasury
44
State of Tennessee, Department of Treasury
Tennessee
– -$31K -21,236 Closed
US Bancorp
45
US Bancorp
Minnesota
– -$18K -12,500 Closed
FI
46
Fosun International
China
– -$18K -11,997 Closed
New York State Common Retirement Fund
47
New York State Common Retirement Fund
New York
– -$9K -6,217 Closed
Bank of Montreal
48
Bank of Montreal
Ontario, Canada
– -$2K -1,066 Closed
Royal Bank of Canada
49
Royal Bank of Canada
Ontario, Canada
– -$1K -1,000 Closed
CIAS
50
Capital Investment Advisory Services
North Carolina
– -$344 -200 -50%
1
2
3

AVDL Hedge Fund Activity: Q2 2019 in Review

45 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Avadel Pharmaceuticals (AVDL) for Q2 2019, worth a combined $55.9M — up 98% from $28.2M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of AVDL and 6 opened new positions — a net loss of 4 holders — while 10 trimmed existing stakes and 13 added.

The largest buyer was Ameriprise, adding an estimated $347K. The largest seller was Acadian Asset Management, cutting an estimated $1.08M.

  • 45 institutional investors held Avadel Pharmaceuticals (AVDL) as of Q2 2019, down from 49 in Q1 2019.
  • Funds reported $55.9M of Avadel Pharmaceuticals stock for Q2 2019, up 98% quarter-over-quarter.
  • 6 funds opened new Avadel Pharmaceuticals positions in Q2 2019 and 10 closed out, a net change of -4 holders.
  • The largest Avadel Pharmaceuticals buyer in Q2 2019 was Ameriprise, an estimated $347K added.
  • The largest Avadel Pharmaceuticals seller in Q2 2019 was Acadian Asset Management, an estimated $1.08M sold.

Based on aggregated 13F filings for Q2 2019.